Besides the recipients of the Sinopharm jabs, authorities in Zhejiang said they had made a Covid-19 vaccine developed by the privately owned pharmaceutical company Sinovac Biotec available to high-risk groups in the east China province under the emergency use scheme.
Exactly how many citizens have received the jabs is unknown, but local and foreign media reports showed images of people lining up outside disease control and prevention centres to receive them.
…
To justify its authorisation of an unproven vaccine, Beijing said the products’ use had been restricted to high-risk individuals, though that included not only obvious groups like frontline health professionals, but also school, supermarket and public transport workers.
